Interactive Chatbot for Cancer

(GIFTT Trial)

This trial tests a digital tool, an interactive chatbot, to assist with genetic counseling via telemedicine. The goal is to enhance how family members of children with cancer learn about significant genetic mutations that might also affect them. It targets parents of children with specific genetic markers linked to cancer who have not yet undergone genetic testing for these markers. Participants must speak and understand English and have no significant communication issues that would prevent them from using the tool. As an unphased trial, this study offers participants the chance to contribute to innovative research that could improve genetic counseling for families.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that chatbots used for genetic counseling are generally safe and well-received by users. One study found that chatbots can effectively assess genetic cancer risks without causing major problems. These digital tools have successfully made genetic services more accessible to patients.

Another study highlighted that chatbots like Invitae Gia® comply with privacy laws, ensuring information remains secure during online chats. Many patients find these chatbots easy to use, enhancing the accessibility of genetic counseling.

Researchers are excited about using an interactive chatbot for cancer because it offers a new way to deliver genetic counseling through digital tools and telemedicine. Unlike traditional face-to-face counseling sessions, this method is more accessible and convenient, especially for patients who live far from medical centers or have mobility issues. Additionally, the chatbot can provide personalized support and information around the clock, making it a flexible option that fits into patients' lives more easily. This innovative approach could revolutionize how we provide support and information to cancer patients, potentially improving their overall experience and outcomes.

Research has shown that chatbots can simplify access to genetic counseling for cancer risk. Studies have found that these chatbots streamline the process of assessing genetic risk, making information more readily available. Both patients and healthcare professionals often trust chatbots to support genetic testing, enhancing value without replacing human experts. Chatbots also help overcome barriers to accessing genetic services, which benefits families dealing with cancer. This technology effectively engages and informs patients about their inherited cancer risks. Overall, chatbots have the potential to make genetic counseling more accessible and efficient.¹²³⁵⁶